FDMT 4D Molecular Corp: Accounting Value per Share

Graphic logo of 4D Molecular Therapeutics (FDMT)

The asset value of 4D Molecular Therapeutics (FDMT) on the GURU.Markets platform, as reflected in this chart, helps assess the success of the brand that created a system for the targeted delivery of gene therapies to the eyes and heart. Business stability is ensured by an autonomous development cycle that remains independent of global crises, with the current indicator standing at 7.42. Cost optimization is achieved by outsourcing all production and testing processes to third-party contractors.

4D Molecular Therapeutics Inc (FDMT) Equity per Share: for the period 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for 4dmoleculartherapeutics.com (FDMT)

- price and consensus price forecast:
Price Chart 4D Molecular Therapeutics Inc|FDMT - Consensus Target
- market capitalization data:
Market Valuation 4D Molecular Therapeutics, Inc.|FDMT - Aggregate Business Value
- book capitalization data:
Book Value per Share 4D Molecular Therapeutics|FDMT - Accounting Capitalization|Market Value to Book Value Ratio 4dmoleculartherapeutics.com|FDMT - Total Business Assets
- debt and liquidity data:
Total Debt to Capital 4D Molecular Therapeutics|FDMT - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio 4D Molecular Therapeutics, Inc.|FDMT - Company Aggregate Debts|Debt to Book Value Ratio 4D Molecular Therapeutics, Inc.|FDMT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings 4D Molecular Therapeutics
Fundamental valuation:4D Molecular Therapeutics Inc - FDMT
Manufactured products of 4D Molecular Therapeutics Inc

Book value per share determines the portion of net assets attributable to a single security, allowing for an assessment of the real value of capital net of all liabilities. This BVPS chart demonstrates the resilience of the financial foundation of 4D Molecular Therapeutics (FDMT), where the capitalization of intellectual property and unique gene therapy methods converts directly into growth in the company's intrinsic value.

Competing companies

TEM: Net Assets per Single Share|Qiagen Corp (QGEN) - Accounting Value per Share|IONS - Accounting Value per Share|repligen.com (RGEN) - Book Price of a Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|SRPT: Book Value per Share|Twist Bioscience, Inc. - Equity per Share|TXG (10x Genomics Inc) - Book Value per Share|NTLA (Intellia) - Equity per Share|Stoke Corp - Accounting Value per Share|Accounting Value of a Share BioLife Solutions, Inc.|Net Assets per Single Share wavelifesciences.com (WVE)|Accounting Value per Share Maze Therapeutics (MAZE)|SION - Net Assets per Single Share|Net Asset Value per Share Prime Medicine Corp PRME|Taysha Corp - Net Assets per Single Share|uniQure N.V. - Net Assets per Single Share|Book Value per Share meiragtx.com|RGNX: Net Asset Value per Share|Book Value per Share Solid Biosciences Inc|Accounting Value per Share OCGN|Accounting Value per Share PacBio Corp|Book Value per Share Benitec Biopharma Inc. (BNTC)|Net Assets per Single Share DSGN (designtx.com)|Net Assets per Single Share RCKT (Rocket Pharmaceuticals, Inc.)|Book Value per Share Lexeo Therapeutics Inc. LXEO|KRRO - Book Value per Share|Net Assets per Single Share EDIT (Editas Corp)|SLN (Silence Therapeutics) - Accounting Value of a Share|ProQR Therapeutics - Accounting Value per Share|Accounting Value of a Share CDXS|SGMO (Sangamo Therapeutics Inc.) - Accounting Value per Share|Book Price of a Share NAUT|MGX (Metagenomi Therapeutics) - Book Value per Share|Accounting Value of a Share DTIL (Precision BioSciences, Inc.)|Generation Bio Co (GBIO) - Book Value per Share|BOLD - Net Asset Value per Share|Net Assets per Single Share XCUR (Exicure, Inc.)|IMNN: Accounting Value of a Share|Phio Pharmaceuticals Corp. (PHIO) - Book Value per Share|Book Value per Share Mustang Bio Inc|TransCode - Net Assets per Single Share|Share Book Value BNGO|APDN - Book Value per Share|Bluebird Bio - Net Asset Value per Share|Accounting Value per Share ImmunoPrecise Antibodies Ltd IPA|OMGA: Book Value per Share|singulargenomics.com - Accounting Value per Share|RGLS: Book Price of a Share|SYRS - Book Value per Share|TBIO (Codex DNA) - Net Assets per Share|Book Value per Share TRACON Pharmaceuticals, Inc (TCON)|Accounting Value per Share Unity Biotechnology (UBX)